24 May 2013
Keywords: ks, biomedix, begins, ph, ii, cb-2431, trial
Article | 24 July 1997
- New UK-based biotechnology company KS Biomedix has started a Phase IItrial of CB-2431, an oral combination product for osteoarthritis. The
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 July 1997
17 July 1997
23 May 2013
© 2013 thepharmaletter.com